唇形科
利什曼病
生物
传统医学
杀虫药
利什曼原虫
抗寄生虫的
人口
医学
生态学
环境卫生
免疫学
寄生虫寄主
体外
病理
万维网
生物化学
计算机科学
作者
Maria Simone Pereira Maciel,Aramys S. Reis,Queli Cristina Fidelis
出处
期刊:Acta Tropica
[Elsevier]
日期:2022-01-13
卷期号:228: 106309-106309
被引量:5
标识
DOI:10.1016/j.actatropica.2022.106309
摘要
Leishmaniasis is a neglected tropical disease present in more than 90 countries and annually affects about 1 million people worldwide. It is caused by the genus Leishmania protozoa that are transmitted to humans by insect bites. This disease is a serious public health problem, which can cause death, disability, and mutilation. The drugs used in treatment have high toxicity, low efficiency, high costs, and possible antiparasitic resistance. Medicinal plant-based treatments have been used for leishmaniasis by population from endemic areas. Among the main botanical families used against leishmaniasis, in different parts of the world, the family Lamiaceae stands out. In this review, the antileishmanial activity of extracts, fractions, and non-volatile compounds of Lamiaceae species are presented. Leishmania species present in the Old and New World were evaluated and discussed. Altogether there are forty-two Lamiaceae species, belonging to twenty-six genera, and ninety-one constituents, isolated from eighteen species of this family, verified in antileishmanial assays. Chemical and biological aspects of extracts, fractions and non-volatile constituents are discussed in order to define a profile of antileishmanial plants of this family, based on the antileishmanial activities results. Notes are presented to guide future investigations to expand chemical and biological knowledge of Lamiaceae species and highlight its most promising antileishmanial agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI